1. Highly Diastereoselective Synthesis of a HCV NS5B Nucleoside Polymerase Inhibitor
- Author
-
Jianguo Yin, David A. Thaisrivongs, Zhijian Liu, Nobuyoshi Yasuda, Adrian Goodyear, Ryan D. Cohen, Antony J. Davies, Brian C. Bishop, Peter R. Mullens, Kevin R. Campos, John Limanto, Ed Cleator, John S. Edwards, Mahbub Alam, Aaron M. Dumas, Hongming Li, Jingjun Yin, Lushi Tan, Zhiguo Jake Song, Yong-Li Zhong, William J. Morris, Michael Shevlin, and Edward C. Sherer
- Subjects
Glycosylation ,Molecular Structure ,010405 organic chemistry ,Stereochemistry ,Organic Chemistry ,Enantioselective synthesis ,Stereoisomerism ,Uracil ,Hepacivirus ,Hepatitis C, Chronic ,Viral Nonstructural Proteins ,010402 general chemistry ,Antiviral Agents ,01 natural sciences ,0104 chemical sciences ,Stereocenter ,chemistry.chemical_compound ,chemistry ,Aldol reaction ,Reagent ,Humans ,NS5B ,Nucleoside - Abstract
An asymmetric synthesis of HCV NS5B nucleoside polymerase inhibitor (1) is described. This novel route features several remarkably diastereoselective and high-yielding transformations, including construction of the all-carbon quaternary stereogenic center at C-2 via a thermodynamic aldol reaction. A subsequent glycosylation reaction with activated uracil via C-1 phosphate and installation of the cyclic phosphate group using an achiral phosphorus(III) reagent followed by oxidation provides 1.
- Published
- 2018
- Full Text
- View/download PDF